YMTX   $13.23  8.62% Market Closed

Yumanity Therapeutics Inc
Last Events:

2022-12-17 Signal in RSI changed from bearish weakening to bullish. RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: entrance to the overbought zone.

2022-12-17 Signal in EMA50 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2022-12-17 Signal in EMA20 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2022-12-17 Signal in Stochastic changed from bearish to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: main and signal line crossing.

2022-12-16 Signal in RSI changed from bearish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

2022-12-16 Signal in EMA100 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2022-12-16 Trend Power changed from almost flat to slow.

2022-12-15 Signal in MACD changed from bullish weakening to bearish reversal. Oscillator MACD is in the positive territory it crossed the signal line from the top and falls. These factors mean that the market confirms the end of the upward trend. Last signal: main and signal line crossing.


Current temperature: 4.90
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 9.64
Target: 35.00
High with 50% probability: 22.42
Analyst Recommendations:
Number of estimates 1
Target Price Mean 35.00
Mean unverified/preliminary 35.00 / 35.00
Target Price Low / High 35.00 / 35.00
Median / STD DEV 35.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Buy ActivelyBuy
rsi ActivelyBuy Buy ActivelyBuy
macd Buy ActivelyBuy -
stoch Sell Sell -
ma20 Sell - -
ma50 Sell - -
ma100 - - -
Candlestick PatternNov. 30, 2022 Dragon Fly - is formed when the opening and the closing prices are at the highest of the day. If it has a longer lower shadow it signals a more bullish trend. When appearing at market bottoms it is considered to be a reversal signal.
ISIN US98872L1026
ceo Dr. Richard Peters M.D., Ph.D.
Website https://www.yumanity.com
Yumanity Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company focuses on discovering disease-modifying therapies to treat neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, amyotrophic lateral sclerosis, and frontotemporal lobar degeneration. Its lead program is YTX-7739, a novel small molecule that is in Phase I clinical trial for the treatment of Parkinson's disease and related disorders of a-synuclein. The company is also developing YTX-9184, which is in preclinical studies to treat neurological disorders. Yumanity Therapeutics Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. The company was founded in 2014 and is headquartered in Boston, Massachusetts.